AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2015
Apr 9, 2015
34825_dirs_2015-04-09_a7862ac8-2380-4db7-8b47-5f621a55c89c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-04-07
Reporting Person: CVF, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-07 | Common Stock | P | 333333 | $6 | Acquired | 2592577 | Direct |
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13